ARROWHEAD PHARMACEUTICALS, INC.（ARWR）内部人交易：高管与董事近期交易
过去 18 个月，共有 12 位内部人为 ARROWHEAD PHARMACEUTICALS, INC.（ARWR）报告了 93 笔 Form 4 交易（最近一笔 2026-08-20）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-20 | OLUKOTUN ADEOYE Y | 董事 | 卖出 | 2,000 | $173,920 |
| 2026-08-20 | PERRY MICHAEL S | 董事 | 卖出 | 11,600 | $1.0M |
| 2026-06-17 | Cohen Matthew Gregory | 董事 | 买入 | 11,882 | $0 |
| 2026-05-14 | Lu Hongbo | 董事 | 卖出 | 2,970 | $228,334 |
| 2026-04-24 | Apel Daniel Joseph | Chief Financial Officer | 卖出 | 3,208 | $224,913 |
| 2026-04-24 | Apel Daniel Joseph | Chief Financial Officer | 卖出 | 1,157 | $81,511 |
| 2026-04-24 | Apel Daniel Joseph | Chief Financial Officer | 卖出 | 8,730 | $627,862 |
| 2026-04-24 | Hamilton James C | Chief Medical Officer | 卖出 | 10,000 | $750,000 |
| 2026-03-09 | Hamilton James C | Chief Medical Officer | 卖出 | 10,000 | $641,900 |
| 2026-01-08 | O'Brien Patrick | COO | 卖出 | 540 | $0 |
| 2026-01-08 | O'Brien Patrick | COO | 卖出 | 540 | $0 |
| 2026-01-08 | O'Brien Patrick | COO | 卖出 | 540 | $0 |
| 2026-01-08 | Apel Daniel Joseph | Chief Financial Officer | 买入 | 75,000 | $0 |
| 2026-01-08 | O'Brien Patrick | COO | 卖出 | 440 | $0 |
| 2026-01-08 | O'Brien Patrick | COO | 卖出 | 440 | $0 |
| 2026-01-08 | O'Brien Patrick | COO | 买入 | 75,000 | $0 |
| 2026-01-08 | Hamilton James C | Chief Medical Officer | 买入 | 75,000 | $0 |
| 2026-01-05 | O'Brien Patrick | COO | 卖出 | 560 | $0 |
| 2026-01-05 | O'Brien Patrick | COO | 卖出 | 560 | $0 |
| 2026-01-05 | O'Brien Patrick | COO | 卖出 | 560 | $0 |
| 2026-01-05 | O'Brien Patrick | COO | 卖出 | 560 | $0 |
| 2026-01-05 | O'Brien Patrick | COO | 卖出 | 560 | $0 |
| 2026-01-05 | O'Brien Patrick | COO | 卖出 | 4,368 | $267,322 |
| 2026-01-05 | O'Brien Patrick | COO | 卖出 | 6,164 | $383,586 |
| 2026-01-05 | O'Brien Patrick | COO | 卖出 | 13,451 | $846,875 |
来源：SEC Form 4 申报文件 · 截至 2026-08-20